Introduction
lished data concerning new technologies and knowledge in their everyday practice. Clinical practice guidelines are systematic statements However, although guidelines may be important in designed to assist doctors in diagnostic and therapeutic promoting quality, they can also be harmful if they do decisions, and have a long tradition in clinical medicine. not really advocate the best options for patients They have been developed by physicians as a means because of scientific uncertainties, biases in guideline of improving the quality of care and objective medical development and/or patient heterogeneity [2] . This decision making, as well as of optimizing the use of was particularly true some years ago (when many resources [1] and thus possibly decreasing healthcare guidelines were consensus-based rather than being expenditure.
explicitly linked to proof of effectiveness), but a greater effort has more recently been made to develop recom-
Risks and benefits of clinical guidelines
mendations based as much as possible on clear-cut data published in the medical literature. Physicians are responsible for offering patients the best Although there is still no methodological consensus available treatment, but their often overloaded sched-as to which approach leads to more valid guidelines, these efforts have certainly improved the scientific Correspondence and offprint requests to: Prof. Dr Francesco Locatelli, quality of those that have been issued more recently, Divisione di Nefrologia e Dialisi, Azienda Ospedale di Lecco, Ospedale A. manzoni, Via Dell 'Eremo 9/11, I-23900 Lecco, Italy.
and their greater emphasis on describing the quality of the data and their degree of uncertainty has made is necessarily wrong but, in order to optimize clinical them precious tools for conscious and judicious outcome, it is important to involve the largest possible decision-making. On the other hand, even high-quality number of nephrologists in order to reach consensus over-standardized medical behaviour may lead to decisions. harmful choices in the case of individual patients.
In March 1995, the National Kidney Foundation Furthermore, non-medical considerations (such as eco-initiated its Dialysis Outcomes Quality Initiative nomic evaluations and the intense pressure that these (NKF-DOQI ) in an effort to create evidence-based, place on health care provision) can also create an best-practice clinical guidelines concerning hemodiaenvironment in which guidelines are misused [3] , as lysis adequacy, peritoneal dialysis adequacy, vascular has been illustrated by the development of certain access and anaemia. The final guidelines were issued guidelines aimed more at limiting access to secondary in the fall of 1997 and represent the first unifying effort care than as a means of assisting clinical decision of the entire renal community. Given the importance making.
of translating these guidelines into clinical practice, a 3-year implementation plan was simultaneously developed and activated by the end of 1997 [12] .
Implementation of clinical guidelines
Subsequently, the European Best Practice Guidelines for the management of anaemia in patients with Despite the efforts made in developing guidelines, chronic renal failure were developed on the basis of strangely little has been done to encourage their impletheir NKF-DOQI counterparts, but with the further mentation. However, as this is the only way of ensuring aim of reflecting European clinical practice and experithat they actually improve healthcare outcomes, it is ence, and including additional publications and new important that an equivalent emphasis is placed on analyses. According to J. S. Cameron [13] , rather than implementation strategies and the scientific evaluation being prescriptive, these guidelines were intended to of their effectiveness in real clinical settings [4] , includprovide clinical guidance on the basis of the best ing the development of local implementation support available evidence: given that every facility has unique systems, clinical audit programmes and methods of people, equipment and procedures, a certain amount feeding back information concerning current practice.
of autonomy is required in order to encompass indiIt is therefore worth adopting a multidisciplinary vidual variation [14] . approach that reflects all of the various aspects of patient care [5] .
A number of serious deficiencies in the adoption of . Being well aware of variations in the management of However, it is also important to bear in mind that ESRD patients, the authors selected three conditions clinical decisions not only depend on published known to affect many patients and to have considerable research data, but also on clinical expertise, patient implications in terms of resources ( line anaemia, renal preferences and the constraints of public health pol-bone disease, and cytomegalovirus disease in renal icies, community standards and budgetary limitations transplant recipients), and evaluated the effects of the [10] .
implementation of the related guidelines in six renal Compliance with clinical guidelines is an important centres in Europe. At the time the study was designed, indicator of quality and efficacy [11] , because an the authors' systematic review of the literature did not improvement in outcome can only be expected if they identify any other similar studies in the nephrological are closely followed. On the other hand, it is likely field, and so this paper is certainly of particular that such an improvement can only be detected in the importance. case that the clinical approach adopted before the Unfortunately, the results were not encouraging and implementation of a guideline was less than good. In the authors concluded: 'In the first European collaborathe presence of an already high standard of medical tion on renal guidelines, the introduction of the guidecare, it is unlikely that practice guidelines will lead to lines improved the monitoring of the patients, but any significant benefits even if they are properly did not improve patient management or outcome'. implemented.
However, despite these negative conclusions, the study has a number of undeniable strong points.
Nephrology guidelines
First of all, its design has the advantage of being prospective, multicentre and randomized, even though (as the authors themselves point out) the adopted None of the many different treatment approaches in the different fields of end-stage renal disease (ESRD) cluster incomplete block design did not exclude the
correct some behaviours without modifying the basic with the same condition. This is therefore neither a classical clinical trial nor an epidemiological study. diet (practice pattern). The essential goals of the DOPPS are to ensure that it represents the target Furthermore, the randomization related to the 'six' units (centres) was based on the pooled nephrologists populations adequately and allows a detailed collection of practice patterns and longitudinal patient data. In of one centre whereas the statistical units (which give the information of interest) are 'the patients' of each contrast, describing the experience of a single centre or convenient group of centres (as is the case of the centre.
Another major strong point is that the study design study by Ramsay et al.) may lead to sacrificing the ability to generalize the findings. The differences in the included an observational period before the implementation of the guidelines was started. This is particu-patients' basic characteristics emphasizes the importance of adjusting for this aspect when evaluating the larly important because it minimizes the risk that spontaneous trends in patient outcomes may have been potential relationships between modifiable practice patterns and patient outcomes because (unlike practice misinterpreted as benefits obtained from the implementation. Thus an analysis of the ESRD patients in patterns) individual patient characteristics are sometimes unchangeable. the Lombardy Registry aimed at clarifying the clinical impact of anaemia and epoietin treatment on general One clear example of this in the study by Ramsay et al. is the large difference in the number of patients and cardiovascular mortality and morbidity found that the mean haematocrit level progressively increased on dialysis at start the of the study in the six centres (between 50 and 170) and, even more strikingly, the from 29% in 1994 to 32% in 1997, which possibly reflects a growing awareness among Lombardy nephrolo-difference in the percentage of patients who started dialysis during the study (between 10% and 97% of gists of the need to correct anaemia better in ESRD patients even before the anaemia management guide-those on dialysis at the beginning). As the authors have not addressed this issue in their paper, we do not lines became formally available. Something similar is likely to occur in relation to many aspects of nephrol-know the reasons for these discrepancies, but these imbalances clearly raise some questions concerning a ogical management, and this must be clearly recognized before assessing the role of guideline implementation possible patient selection bias.
Returning to the conclusions of the study, we wonder on outcomes.
One point of weakness of the study is that it is not about the usefulness of improving patient monitoring if this has no effect in terms of improving patient clear how the five European countries were selected and the six centres representing them were not random-management or outcome. Although we agree that the results of the study support the potential of creating ized. This is important because the authors themselves point out that there are not only international, but clinical guidelines with the aim of standardizing treatment protocols across international boundaries, it is also national variations in the management of patients with ESRD [16 ] . The authors recognize that the selec-more difficult to conclude that this in itself may improve the quality of medical care (which unfortution of the centres precluded any generalization of the results and state that 'it was important to have a group nately remains a distant hope). The results are particularly frustrating because, as the authors point out, the of well-motivated nephrologists and methodologists (working together)' and 'there was a significant intervention was very correct and above all demanding for the centres. centre effect'. This aspect has been properly managed in the ongoAlthough the (albeit statistically significant) result of only a 6% improvement in patient monitoring ing Dialysis Outcome and Practice Patterns Study (DOPPS ) [17], a prospective, longitudinal, observa-between the guideline and control centres is disappointing, the authors believe that it provides some tional study of haemodialysis patients and facilities in seven countries with large populations of dialysis evidence in favour of the view that guidelines increase the adherence to (and probably the the frequency of ) patients: France, Germany, Italy, Japan, Spain, the United Kingdom and the United States. The aim of appropriate investigations. However, in comparison with the guideline centres, there were paradoxical the study is to determine which practice patterns are associated with the best patient outcomes, after adjust-improvements in patient management (4%) and outcome (7%) in the control centres, which were strangely ment for a wide range of patient case-mix characteristics. The DOPPS has not only demonstrated that this of the same magnitude as the improvement in monitoring although of only borderline statistical significkind of study is technically feasible, but has also revealed basic differences among centres that vary ance (CI: −1%/+9% and −1%/14%, respectively). It is perhaps worth remembering that P values kill a lot widely in terms of their size, type and patients in the seven participating countries. The particular character-of patients! As already mentioned, another very important istic of the DOPPS is that it is designed to detect the associations between practice patterns and outcomes, aspect of the evaluation of guideline implementation is the 'ceiling effect': as the author's point out, when thus possibly modifying the practice pattern only if there is a clear suggestion that one practice is actually the outcome is already relatively good, it is difficult to 6. Davis DA, Taylor-Vaisey A. Translating guidelines into practice.
improve it further. However, although this was true in A systematic review of theoretic concepts, practical experience relation to the management of anaemia (95% before and research evidence in the adoption of clinical practice guidethe guidelines were introduced ), it was not the case in 
